Skip to main content
. 2015 Sep 5;32(8):742–756. doi: 10.1007/s12325-015-0233-1

Fig. 3.

Fig. 3

Sensitivity analyses of projected drug cost savings due to the introduction of Remsima; 30% discount scenario. M million